COVID-19 Impact on Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 94 pages | ID: C3079824B92DEN
QYResearch

Abstracts

This report focuses on the global Obsessive-Compulsive Disorder Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Obsessive-Compulsive Disorder Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Eli Lilly and Co.
• GlaxoSmithKline Plc
• H. Lundbeck AS
• Novartis AG
• Pfizer Inc.
• ...

Market segment by Type, the product can be split into

• SSRI
• TCA
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Research Institute
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Obsessive-Compulsive Disorder Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Obsessive-Compulsive Disorder Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Obsessive-Compulsive Disorder Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Obsessive-Compulsive Disorder Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 SSRI
  1.4.3 TCA
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Obsessive-Compulsive Disorder Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Research Institute
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Obsessive-Compulsive Disorder Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Obsessive-Compulsive Disorder Drugs Industry
    1.6.1.1 Obsessive-Compulsive Disorder Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Obsessive-Compulsive Disorder Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Obsessive-Compulsive Disorder Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Obsessive-Compulsive Disorder Drugs Market Perspective (2015-2026)
2.2 Obsessive-Compulsive Disorder Drugs Growth Trends by Regions
  2.2.1 Obsessive-Compulsive Disorder Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Obsessive-Compulsive Disorder Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Obsessive-Compulsive Disorder Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Obsessive-Compulsive Disorder Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Obsessive-Compulsive Disorder Drugs Players by Market Size
  3.1.1 Global Top Obsessive-Compulsive Disorder Drugs Players by Revenue (2015-2020)
  3.1.2 Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Obsessive-Compulsive Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Obsessive-Compulsive Disorder Drugs Market Concentration Ratio
  3.2.1 Global Obsessive-Compulsive Disorder Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Obsessive-Compulsive Disorder Drugs Revenue in 2019
3.3 Obsessive-Compulsive Disorder Drugs Key Players Head office and Area Served
3.4 Key Players Obsessive-Compulsive Disorder Drugs Product Solution and Service
3.5 Date of Enter into Obsessive-Compulsive Disorder Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Obsessive-Compulsive Disorder Drugs Historic Market Size by Type (2015-2020)
4.2 Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Type (2021-2026)

5 OBSESSIVE-COMPULSIVE DISORDER DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)
5.2 Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Obsessive-Compulsive Disorder Drugs Market Size (2015-2020)
6.2 Obsessive-Compulsive Disorder Drugs Key Players in North America (2019-2020)
6.3 North America Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020)
6.4 North America Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Obsessive-Compulsive Disorder Drugs Market Size (2015-2020)
7.2 Obsessive-Compulsive Disorder Drugs Key Players in Europe (2019-2020)
7.3 Europe Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020)
7.4 Europe Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Obsessive-Compulsive Disorder Drugs Market Size (2015-2020)
8.2 Obsessive-Compulsive Disorder Drugs Key Players in China (2019-2020)
8.3 China Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020)
8.4 China Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Obsessive-Compulsive Disorder Drugs Market Size (2015-2020)
9.2 Obsessive-Compulsive Disorder Drugs Key Players in Japan (2019-2020)
9.3 Japan Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020)
9.4 Japan Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size (2015-2020)
10.2 Obsessive-Compulsive Disorder Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Obsessive-Compulsive Disorder Drugs Market Size (2015-2020)
11.2 Obsessive-Compulsive Disorder Drugs Key Players in India (2019-2020)
11.3 India Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020)
11.4 India Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Obsessive-Compulsive Disorder Drugs Market Size (2015-2020)
12.2 Obsessive-Compulsive Disorder Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020)
12.4 Central & South America Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Eli Lilly and Co.
  13.1.1 Eli Lilly and Co. Company Details
  13.1.2 Eli Lilly and Co. Business Overview and Its Total Revenue
  13.1.3 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Introduction
  13.1.4 Eli Lilly and Co. Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020))
  13.1.5 Eli Lilly and Co. Recent Development
13.2 GlaxoSmithKline Plc
  13.2.1 GlaxoSmithKline Plc Company Details
  13.2.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Introduction
  13.2.4 GlaxoSmithKline Plc Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
  13.2.5 GlaxoSmithKline Plc Recent Development
13.3 H. Lundbeck AS
  13.3.1 H. Lundbeck AS Company Details
  13.3.2 H. Lundbeck AS Business Overview and Its Total Revenue
  13.3.3 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Introduction
  13.3.4 H. Lundbeck AS Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
  13.3.5 H. Lundbeck AS Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Obsessive-Compulsive Disorder Drugs Introduction
  13.4.4 Novartis AG Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 Pfizer Inc.
  13.5.1 Pfizer Inc. Company Details
  13.5.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.5.3 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Introduction
  13.5.4 Pfizer Inc. Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
  13.5.5 Pfizer Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Obsessive-Compulsive Disorder Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Obsessive-Compulsive Disorder Drugs Revenue
Table 3. Ranking of Global Top Obsessive-Compulsive Disorder Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of SSRI
Table 6. Key Players of TCA
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Obsessive-Compulsive Disorder Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Obsessive-Compulsive Disorder Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Obsessive-Compulsive Disorder Drugs Players to Combat Covid-19 Impact
Table 13. Global Obsessive-Compulsive Disorder Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Obsessive-Compulsive Disorder Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Obsessive-Compulsive Disorder Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions (2015-2020)
Table 17. Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Obsessive-Compulsive Disorder Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Obsessive-Compulsive Disorder Drugs Players
Table 24. Global Obsessive-Compulsive Disorder Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Obsessive-Compulsive Disorder Drugs Market Share by Players (2015-2020)
Table 26. Global Top Obsessive-Compulsive Disorder Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obsessive-Compulsive Disorder Drugs as of 2019)
Table 27. Global Obsessive-Compulsive Disorder Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Obsessive-Compulsive Disorder Drugs Product Solution and Service
Table 30. Date of Enter into Obsessive-Compulsive Disorder Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Obsessive-Compulsive Disorder Drugs Market Size Share by Type (2015-2020)
Table 34. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Obsessive-Compulsive Disorder Drugs Market Size Share by Application (2015-2020)
Table 36. Global Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Obsessive-Compulsive Disorder Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Obsessive-Compulsive Disorder Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Obsessive-Compulsive Disorder Drugs Market Share (2019-2020)
Table 40. North America Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Obsessive-Compulsive Disorder Drugs Market Share by Type (2015-2020)
Table 42. North America Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Obsessive-Compulsive Disorder Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Obsessive-Compulsive Disorder Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Obsessive-Compulsive Disorder Drugs Market Share (2019-2020)
Table 46. Europe Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Obsessive-Compulsive Disorder Drugs Market Share by Type (2015-2020)
Table 48. Europe Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Obsessive-Compulsive Disorder Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Obsessive-Compulsive Disorder Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Obsessive-Compulsive Disorder Drugs Market Share (2019-2020)
Table 52. China Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Obsessive-Compulsive Disorder Drugs Market Share by Type (2015-2020)
Table 54. China Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Obsessive-Compulsive Disorder Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Obsessive-Compulsive Disorder Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Obsessive-Compulsive Disorder Drugs Market Share (2019-2020)
Table 58. Japan Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Obsessive-Compulsive Disorder Drugs Market Share by Type (2015-2020)
Table 60. Japan Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Obsessive-Compulsive Disorder Drugs Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Obsessive-Compulsive Disorder Drugs Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Obsessive-Compulsive Disorder Drugs Market Share (2019-2020)
Table 64. Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Obsessive-Compulsive Disorder Drugs Market Share by Type (2015-2020)
Table 66. Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Obsessive-Compulsive Disorder Drugs Market Share by Application (2015-2020)
Table 68. India Key Players Obsessive-Compulsive Disorder Drugs Revenue (2019-2020) (Million US$)
Table 69. India Key Players Obsessive-Compulsive Disorder Drugs Market Share (2019-2020)
Table 70. India Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. India Obsessive-Compulsive Disorder Drugs Market Share by Type (2015-2020)
Table 72. India Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. India Obsessive-Compulsive Disorder Drugs Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Obsessive-Compulsive Disorder Drugs Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Obsessive-Compulsive Disorder Drugs Market Share (2019-2020)
Table 76. Central & South America Obsessive-Compulsive Disorder Drugs Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Obsessive-Compulsive Disorder Drugs Market Share by Type (2015-2020)
Table 78. Central & South America Obsessive-Compulsive Disorder Drugs Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Obsessive-Compulsive Disorder Drugs Market Share by Application (2015-2020)
Table 80. Eli Lilly and Co. Company Details
Table 81. Eli Lilly and Co. Business Overview
Table 82. Eli Lilly and Co. Product
Table 83. Eli Lilly and Co. Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020) (Million US$)
Table 84. Eli Lilly and Co. Recent Development
Table 85. GlaxoSmithKline Plc Company Details
Table 86. GlaxoSmithKline Plc Business Overview
Table 87. GlaxoSmithKline Plc Product
Table 88. GlaxoSmithKline Plc Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020) (Million US$)
Table 89. GlaxoSmithKline Plc Recent Development
Table 90. H. Lundbeck AS Company Details
Table 91. H. Lundbeck AS Business Overview
Table 92. H. Lundbeck AS Product
Table 93. H. Lundbeck AS Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020) (Million US$)
Table 94. H. Lundbeck AS Recent Development
Table 95. Novartis AG Company Details
Table 96. Novartis AG Business Overview
Table 97. Novartis AG Product
Table 98. Novartis AG Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020) (Million US$)
Table 99. Novartis AG Recent Development
Table 100. Pfizer Inc. Company Details
Table 101. Pfizer Inc. Business Overview
Table 102. Pfizer Inc. Product
Table 103. Pfizer Inc. Revenue in Obsessive-Compulsive Disorder Drugs Business (2015-2020) (Million US$)
Table 104. Pfizer Inc. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Obsessive-Compulsive Disorder Drugs Market Share by Type: 2020 VS 2026
Figure 2. SSRI Features
Figure 3. TCA Features
Figure 4. Others Features
Figure 5. Global Obsessive-Compulsive Disorder Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Obsessive-Compulsive Disorder Drugs Report Years Considered
Figure 11. Global Obsessive-Compulsive Disorder Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Obsessive-Compulsive Disorder Drugs Market Share by Players in 2019
Figure 16. Global Top Obsessive-Compulsive Disorder Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obsessive-Compulsive Disorder Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Obsessive-Compulsive Disorder Drugs Revenue in 2019
Figure 18. North America Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Eli Lilly and Co. Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
Figure 27. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Plc Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
Figure 29. H. Lundbeck AS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. H. Lundbeck AS Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
Figure 31. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis AG Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
Figure 33. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc. Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed